Pacific Biosciences Of California reported $782.36M in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Agilent USD 13.07B 252M Mar/2026
Bruker USD 6.13B 110.7M Mar/2026
Danaher USD 83.54B 80M Mar/2026
General Electric Aerospace USD 128.45B 1.72B Mar/2026
Illumina USD 6.56B 85M Mar/2026
Myriad Genetics USD 673.7M 32.9M Mar/2026
Pacific Biosciences Of California USD 782.36M 1.72M Mar/2026
Quidel USD 5.63B 140.6M Mar/2026
Revvity USD 12B 171.82M Mar/2026
Roche Holding CHF 100.7B 5.94B Dec/2025
Standard Biotools USD 639.11M 71.36M Mar/2026
Thermo Fisher Scientific USD 113.28B 2.94B Mar/2026
Waters USD 24.53B 19.45B Mar/2026